Vancomycin Dosing and Monitoring in Acute Bacterial Meningitis

Initial Dosing Strategy

• Give 15–20 mg/kg vancomycin intravenously every 8–12 hours based on actual body weight (including obese patients), with each individual dose capped at 2 g. This regimen achieves the higher trough concentrations required for meningitis. 1, 2
• For critically ill patients with suspected MRSA meningitis, start with a loading dose of 25–30 mg/kg (actual body weight) to reach therapeutic levels rapidly. 1
• When a single dose exceeds 1 g, infuse the dose over 1.5–2 hours to lessen the risk of red‑man syndrome. 1, 3

Determining Dosing Frequency

• Patients with normal renal function generally require dosing every 8–12 hours to maintain target troughs. The exact interval (8 h vs 12 h) should be guided by measured trough concentrations and renal function, not by creatinine‑clearance formulas alone. 1, 2, 3

Therapeutic Drug Monitoring (TDM)

• Target vancomycin trough serum concentrations of 15–20 mg/L for meningitis to ensure adequate CNS penetration and an AUC/MIC ≥ 400. 1, 2, 3
• Obtain the first trough level immediately before the fourth dose (approximately 48–72 hours after initiation, when steady state is reached). 2, 3
• Trough monitoring is the preferred and most practical method; routine peak‑level measurement is not recommended. 1, 2
• In patients with unstable renal function or those receiving prolonged therapy, repeat trough measurement before every fourth dose. Dose adjustments should be based on these trough values rather than on standard nomograms, which are not designed for the higher targets needed in meningitis. 2, 3

Renal‑Function–Based Dose Adjustments

• Do not apply standard creatinine‑clearance‑based dose‑reduction formulas for meningitis, as they can produce subtherapeutic CSF concentrations. Initial dosing should be weight‑based, followed by adjustments guided by measured troughs. 2, 3
• For patients with renal impairment, extend the dosing interval (e.g., every 24–48 hours) instead of lowering the individual dose, to preserve adequate peak concentrations for CSF penetration. Verify achievement of the 15–20 mg/L trough target regardless of renal function. 3, 2
• A common pitfall is using non‑CNS vancomycin regimens that aim for troughs of 10–15 mg/L, which may lead to treatment failure in meningitis. 2, 3

Alternative Agents for Vancomycin Allergy or Failure

• Pneumococcal meningitis: Continue ceftriaxone 2 g IV every 12 hours or cefotaxime 2 g IV every 6 hours when the isolate is susceptible. If the pathogen is resistant to both penicillins and cephalosporins, add rifampin 600 mg orally or intravenously twice daily. 4
• MRSA meningitis: Use linezolid 600 mg orally or intravenously every 12 hours as the preferred alternative because of excellent CSF penetration. TMP‑SMX 5 mg/kg intravenously every 8–12 hours is an additional option. Daptomycin is not recommended due to poor CSF penetration and inactivation by pulmonary surfactant. 1

MIC‑Based Decision Making

• If the vancomycin MIC is ≥ 2 mg/L, switch to an alternative therapy because achieving an AUC/MIC ≥ 400 is unlikely with conventional dosing in patients with normal renal function. 2, 3
• When the MIC is ≤ 1 mg/L, maintaining troughs of 15–20 mg/L should provide adequate AUC/MIC ratios for effective treatment. 2, 3

Duration of Therapy

• For MRSA septic thrombosis of the cavernous or dural venous sinus, treat with vancomycin (or an appropriate alternative) for 4–6 weeks. 1

Nephrotoxicity Monitoring

• Check serum creatinine regularly throughout vancomycin therapy.
• Define vancomycin‑induced nephrotoxicity as ≥ 2–3 consecutive rises in serum creatinine of ≥ 0.5 mg/dL (or ≥ 50 % from baseline) after several days of treatment, in the absence of other explanations. 3
• The risk of nephrotoxicity increases when trough concentrations exceed 20 mg/L and when concurrent nephrotoxic agents are used. 3

Vancomycin Dosing for Acute Meningitis

Empiric Therapy for Meningitis

• The Infectious Diseases Society of America recommends vancomycin at a dose of 15-20 mg/kg IV every 12 hours for suspected bacterial meningitis when penicillin-resistant pneumococci is a possibility, particularly for patients who have recently traveled to regions with high rates of pneumococcal resistance 5, 6
• Vancomycin should be used in combination with a third-generation cephalosporin, such as ceftriaxone 2g IV every 12 hours or cefotaxime 2g IV every 6 hours, for empiric therapy of meningitis 5, 6, 7

Pathogen-Specific Therapy

Pneumococcal Meningitis

• For penicillin and cephalosporin-resistant Streptococcus pneumoniae, the American Academy of Pediatrics and the Infectious Diseases Society of America recommend continuing ceftriaxone 2g IV every 12 hours or cefotaxime 2g IV every 6 hours plus vancomycin 15-20 mg/kg IV every 12 hours 5, 6
• Consider adding rifampin 600 mg orally/IV twice daily in cases of dual resistance, as suggested by the Infectious Diseases Society of America 5, 6
• Treatment duration should be 10-14 days for patients who have recovered by day 10, and extended to 14 days for those with penicillin or cephalosporin-resistant pneumococcal meningitis, according to the Infectious Diseases Society of America 5, 6

Staphylococcal Meningitis (including MRSA)

• For methicillin-resistant Staphylococcus aureus meningitis, the Infectious Diseases Society of America recommends vancomycin at 15-20 mg/kg IV every 8-12 hours 8, 9
• Some experts recommend adding rifampin 600 mg daily or 300-450 mg twice daily to vancomycin for better CNS penetration, as suggested by the Infectious Diseases Society of America 8, 9

Special Considerations

• For post-neurosurgical meningitis, the Infectious Diseases Society of America recommends the same dosing regimen of vancomycin (15-20 mg/kg IV every 12 hours) 9
• Duration of therapy should be at least 10-14 days for uncomplicated cases with good clinical response, according to the Infectious Diseases Society of America 9

Vancomycin Dosing for Acute Meningitis

Indications for Vancomycin in Meningitis

• Vancomycin is indicated as part of empiric therapy when penicillin-resistant pneumococci is suspected or for confirmed cases of resistant pneumococcal or staphylococcal meningitis 10
• For penicillin and cephalosporin non-susceptible Streptococcus pneumoniae, vancomycin should be added to the treatment regimen 11, 12, 13

Dosing Recommendations

• Initial dosing: 15-20 mg/kg IV every 8-12 hours for adults 14, 10
• Pediatric dosing: 15 mg/kg IV every 6 hours 10

Therapeutic Monitoring

• Obtain trough serum vancomycin concentrations just before the fourth dose (at steady state) 14
• Target trough serum concentrations of 15-20 mg/L for meningitis to ensure adequate CNS penetration 14
• More frequent monitoring is recommended in patients with unstable renal function 14

Special Considerations

• Consider alternative therapy if the vancomycin MIC is ≥2 mg/L, as target AUC/MIC ratios >400 may not be achievable with conventional dosing 14
• Some experts recommend adding rifampin 600 mg daily or 300-450 mg twice daily to vancomycin for better CNS penetration in staphylococcal meningitis 10

Duration of Therapy

• For pneumococcal meningitis: 10-14 days 11, 12, 13
• For staphylococcal meningitis: 14 days 10
• Treatment duration may need to be extended if clinical response is delayed 11, 12, 13

Monitoring for Adverse Effects

• Monitor renal function regularly during therapy 14
• Vancomycin-induced nephrotoxicity is defined as multiple (at least 2-3 consecutive) increases in serum creatinine (increase of 0.5 mg/dL or 150% increase from baseline) after several days of therapy 14